TNDM:NASDAQ
Tandem Diabetes Care Inc
US$Â 16,42
0,00%
(0,00) 1D
US$Â 16,40
arrow_downward
-0,12% (-0,020)todayVóór openingstijd
Gesloten: 28 sep, 16:00:00 GMT-4 · USD
search
Alle symbolen
1D
5D
1M
6M
YTD
1J
5J
MAX
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor TNDM genereren…
Beursw.
1,14Â mld.
Gem. vol.
1,89Â mln.
Volume
0,00
52 wk hoog
US$Â 29,65
52 wk laag
US$Â 11,46
WPA
US$Â -0,93
Bèta
1,55
Uitstaande aandelen
69,58Â mln.
Aantal medewerkers
2K
Beursw.
1,14Â mld.
Gem. vol.
1,89Â mln.
Volume
0,00
52 wk hoog
US$Â 29,65
52 wk laag
US$Â 11,46
WPA
US$Â -0,93
Bèta
1,55
Uitstaande aandelen
69,58Â mln.
Aantal medewerkers
2K
Nieuwsartikelen
Van webbronnen en nieuwspartners
Simply Wall Street
·
22 uur geleden
Tandem Diabetes Care (TNDM) Could Be 46% Undervalued As Mobi Reaches 12 Markets
Stock Titan
·
1 dag geleden
A diabetes pump small enough for a jeans coin pocket is now shipping abroad
Profiel
Tandem Diabetes Care, Inc. is an American medical-device company that develops and markets insulin pumps, automated insulin delivery systems and diabetes-management software. Headquartered in San Diego, California, its principal pump platforms are the t:slim X2 and Tandem Mobi, both of which use the company's Control-IQ+ software with compatible continuous glucose monitors.
Tandem was founded in 2006 and introduced its first pump, the touchscreen t:slim, in 2012. The company became publicly traded on the Nasdaq in 2013. By the end of 2025 it reported an in-warranty user base of nearly 500,000 people in more than 25 countries and annual sales of $1.015 billion. Wikipedia
Over Tandem Diabetes Care Inc